Pharma Focus Asia
KP - Sustainable Packaging Solutions

MSD Invests US$1.18 billion (€1 billion) to Expand Footprint in Ireland


MSD invests US$1.18 billion (€1 billion) to expand its facilities in Dunboyne and Carlow, both situated in Ireland.


The new expansion is poised to enhance global manufacturing capacity significantly, allowing to effectively address the rising need for its medicines and vaccines worldwide.

These two facilities are set to deliver substantial improvements in manufacturing capabilities, thereby empowering the global network to effectively respond to the ever-evolving global demand for vaccines and medicines.

These new facilities will result in the generation of 100 new employment opportunities. These positions will encompass a diverse array of crucial roles, including engineering, scientific research, manufacturing operations, quality control, and various other vital functions.

Both the expansion in Carlow and the opening of the new MSD Dunboyne facility hold pivotal roles in MSD's global operations. Carlow site plays a crucial role for filling and commercial supply of vaccines, biologics, and small molecule drug products, facilitating their launch and distribution.


Name   MSD
Type   Expansion
Budget US$1.18 billion (€1 billion)

Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024CPHI Chine || PMEC China 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024CPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?